Renaissance School of Medicine at Stony Brook University, United States
👨🎓Profiles
🎓 Early Academic Pursuits
Dr. Carlos Tirado began his scientific journey with a Ph.D. from Arizona State University, laying a strong foundation in molecular biology and genetics. His passion for cytogenetics led him to pursue specialized training at Duke University Medical Center, where he completed a Clinical Cytogenetics Fellowship. His early academic choices reflected a deep commitment to advancing the understanding of chromosomal science in medicine.
🧬 Professional Endeavors and Career Milestones
Dr. Tirado’s extensive professional career spans several leading institutions across the United States. He currently serves as Visiting Professor and Head of Cytogenetics in the Department of Pathology at the Renaissance School of Medicine, Stony Brook University. He previously served as Chief of Cytogenetics at Baylor Scott & White in Temple, Texas, and held concurrent roles as Adjunct Associate Clinical Professor at Texas A&M. His prior appointments include Director of Cytogenetics at Allina Health in Minneapolis, Associate Professor at UCLA, and Assistant Professor roles at the University of Texas Southwestern and the University of California. Earlier in his career, he held academic roles in Peru at Universidad Peruana Cayetano Heredia.
🔬 Contributions and Research Focus
Dr. Tirado’s research focuses on clinical cytogenetics, particularly in the diagnosis and understanding of cancer genomics, human chromosomal variation, and molecular diagnostics. He has been involved in several funded research projects as Principal Investigator and Co-Investigator, contributing to diagnostic advancements in hematologic malignancies and cytogenetic methodologies. His work bridges the clinical laboratory with cutting-edge translational research, advancing precision medicine in pathology.
🌍 Impact and Influence
Dr. Tirado’s influence is global. He has served as Chairman and Organizer of the International Symposium of Cytogenetics & Molecular Biology and as Meeting Director for the Annual Joint Meetings of the Association of Genetic Technologists (AGT). These roles have positioned him as a leader in fostering scientific collaboration and knowledge exchange on an international scale. His early recognition as a Fulbright Scholar marked the beginning of his lifelong commitment to academic excellence and international engagement.
📚 Academic Citations and Scholarly Recognition
Dr. Tirado’s research contributions are widely cited, including highly referenced work on childhood B-acute lymphoblastic leukemia and telomerase biology. His scholarly outputs include peer-reviewed journal articles, abstracts, and invited talks at major international symposia. As a mentor, his name appears alongside underlined mentees in joint publications, showcasing his dedication to academic guidance and legacy building.
🧪 Technical and Diagnostic Expertise
His diagnostic expertise spans advanced cytogenetic techniques including FISH, karyotyping, chromosomal microarray, and next-generation sequencing. He holds multiple board certifications and active state licensures in New York, California, and Florida as a Clinical Cytogenetics Director. His leadership in laboratory quality control (QA/QC) and training reflects his excellence in clinical laboratory operations and regulatory compliance.
👨🏫 Teaching Experience and Mentorship
Dr. Tirado has held key academic teaching roles, mentoring medical students, residents, and fellows at institutions such as Texas A&M, the University of Minnesota, and UCLA. He directed CLS training programs certified by the State of California and served on multiple admissions committees. His dedication to pedagogy was recognized with a Special Educator Award from the Center for Excellence in Learning and Teaching (CELT) at Stony Brook University.
🏅 Awards and Honors
Among his recognitions are the Fulbright Scholar Award and the Special Educator Award, which underscore his excellence in both scholarly achievement and educational leadership. These accolades highlight his dual impact on science and teaching.
🌟 Legacy and Future Contributions
Dr. Carlos Tirado continues to shape the future of cytogenetics and genomic pathology. Through his involvement in international symposia, academic leadership, and mentorship, he promotes the advancement of diagnostic genomics and translational medicine. His legacy is rooted in a dedication to global collaboration, innovative diagnostics, and training the next generation of clinician-scientists in human genetics.
📖Notable Publications
Childhood B-acute lymphoblastic leukemia: a genetic update
Authors: JS Woo, MO Alberti, CA Tirado
Journal: Experimental Hematology & Oncology, 3, 1–14
Year: 2014
C-terminal regions of the human telomerase catalytic subunit essential for in vivo enzyme activity
Authors: SSR Banik, C Guo, AC Smith, SS Margolis, DA Richardson, CA Tirado, …
Journal: Molecular and Cellular Biology, 22 (17), 6234–6246
Year: 2002
ATR functions as a gene dosage‐dependent tumor suppressor on a mismatch repair‐deficient background
Authors: Y Fang, CC Tsao, BK Goodman, R Furumai, CA Tirado, RT Abraham, …
Journal: The EMBO Journal, 23 (15), 3164–3174
Year: 2004
Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet‐derived growth factor receptor–alpha genes in …
Authors: AM Safley, S Sebastian, TS Collins, CA Tirado, TT Stenzel, JZ Gong, …
Journal: Genes, Chromosomes and Cancer, 40 (1), 44–50
Year: 2004
Genomic profiling using array comparative genomic hybridization defines distinct subtypes of diffuse large B-cell lymphoma: a review of the literature
Authors: CA Tirado, W Chen, R García, KA Kohlman, N Rao
Journal: Journal of Hematology & Oncology, 5, 1–12
Year: 2012
t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature
Authors: JJ Wakim, CA Tirado, W Chen, R Collins
Journal: Leukemia Research, 35 (9), e151–e153
Year: 2011